Progestin Injection

Form: Injection

Strength: 50 mg/mL, 100 mg/mL

Reference Brands: Depo-subQ Provera 104(US)

Category: Oncology Cancer Care

Progestin Injection (50 mg/mL and 100 mg/mL), often in the form of Medroxyprogesterone acetate, is used in oncology to manage hormone receptor-positive breast cancer, recurrent endometrial cancer, and palliative care for various cancer symptoms. Approved in both the U.S. and EU, it plays a critical role in hormonal therapy, working to slow cancer progression by blocking hormone receptors. Available as an IM or subcutaneous injection, it is a key drug in oncology B2B distribution, supporting hospitals and cancer treatment centers with its ability to control tumor growth and improve patient quality of life.